{"id":355933,"date":"2026-11-19T16:05:07","date_gmt":"2026-11-19T10:35:07","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=355933"},"modified":"2026-11-19T16:05:07","modified_gmt":"2026-11-19T10:35:07","slug":"pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/","title":{"rendered":"3 Pathology Labs Chain, Fertilisers Maker and Digital Operations Company Stocks With a Strong Future Roadmap: Metropolis Healthcare, Chambal Fertilisers and Chemicals and eClerx Services"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Metropolis Healthcare, Chambal Fertilisers and Chemicals and eClerx Services: ROE of 12.6% to 27.6% and FY22 to FY26 revenue CAGR of 6.7% to 17.9%. Prices as of 18 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three <strong>blood test lab, urea and data process stocks<\/strong> to watch are <strong>Metropolis Healthcare<\/strong>, <strong>Chambal Fertilisers and Chemicals<\/strong> and <strong>eClerx Services<\/strong>. Their <strong>return on equity<\/strong> ranges from <strong>12.6% to 27.6%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 6.7% to 17.9%. eClerx Services leads on both return on equity at 27.6% and revenue growth at 17.9% a year. Prices are based on the 18 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Blood test lab, urea and data process stocks give investors a way to track businesses that sit close to everyday demand in India. Metropolis Healthcare, Chambal Fertilisers and Chemicals and eClerx Services cover a pathology labs chain, a fertilisers maker and a digital operations company.<\/p>\n<p>This list covers three blood test lab, urea and data process stocks with complete current figures: Metropolis Healthcare, Chambal Fertilisers and Chemicals and eClerx Services. Every figure comes from the latest reported financials and the 18 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#What_Are_Blood_Test_Lab_Urea_and_Data_Process_Stocks\" title=\"What Are Blood Test Lab, Urea and Data Process Stocks?\">What Are Blood Test Lab, Urea and Data Process Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#Blood_Test_Lab_Urea_and_Data_Process_Stocks_at_a_Glance\" title=\"Blood Test Lab, Urea and Data Process Stocks at a Glance\">Blood Test Lab, Urea and Data Process Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#Why_Do_Blood_Test_Lab_Urea_and_Data_Process_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Blood Test Lab, Urea and Data Process Stocks Have a Strong Roadmap in India?\">Why Do Blood Test Lab, Urea and Data Process Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#Why_Metropolis_Healthcare_Features_Among_These_Blood_Test_Lab_Urea_and_Data_Process_Stocks\" title=\"Why Metropolis Healthcare Features Among These Blood Test Lab, Urea and Data Process Stocks\">Why Metropolis Healthcare Features Among These Blood Test Lab, Urea and Data Process Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#Why_Chambal_Fertilisers_and_Chemicals_Features_Among_These_Blood_Test_Lab_Urea_and_Data_Process_Stocks\" title=\"Why Chambal Fertilisers and Chemicals Features Among These Blood Test Lab, Urea and Data Process Stocks\">Why Chambal Fertilisers and Chemicals Features Among These Blood Test Lab, Urea and Data Process Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#Why_eClerx_Services_Features_Among_These_Blood_Test_Lab_Urea_and_Data_Process_Stocks\" title=\"Why eClerx Services Features Among These Blood Test Lab, Urea and Data Process Stocks\">Why eClerx Services Features Among These Blood Test Lab, Urea and Data Process Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#Metropolis_Healthcare_vs_Chambal_Fertilisers_and_Chemicals_vs_eClerx_Services_on_Key_Financials\" title=\"Metropolis Healthcare vs Chambal Fertilisers and Chemicals vs eClerx Services on Key Financials\">Metropolis Healthcare vs Chambal Fertilisers and Chemicals vs eClerx Services on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#Key_Risks_to_Check_Before_Investing_in_Blood_Test_Lab_Urea_and_Data_Process_Stocks\" title=\"Key Risks to Check Before Investing in Blood Test Lab, Urea and Data Process Stocks\">Key Risks to Check Before Investing in Blood Test Lab, Urea and Data Process Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#Final_Thoughts_on_Blood_Test_Lab_Urea_and_Data_Process_Stocks\" title=\"Final Thoughts on Blood Test Lab, Urea and Data Process Stocks\">Final Thoughts on Blood Test Lab, Urea and Data Process Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#What_are_blood_test_lab_urea_and_data_process_stocks\" title=\"What are blood test lab, urea and data process stocks?\">What are blood test lab, urea and data process stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#Which_blood_test_lab_urea_and_data_process_stocks_are_covered_in_this_list\" title=\"Which blood test lab, urea and data process stocks are covered in this list?\">Which blood test lab, urea and data process stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#Why_do_blood_test_lab_urea_and_data_process_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do blood test lab, urea and data process stocks have a strong future roadmap in India?\">Why do blood test lab, urea and data process stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#How_has_Metropolis_Healthcare_performed_financially\" title=\"How has Metropolis Healthcare performed financially?\">How has Metropolis Healthcare performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#How_has_Chambal_Fertilisers_and_Chemicals_performed_financially\" title=\"How has Chambal Fertilisers and Chemicals performed financially?\">How has Chambal Fertilisers and Chemicals performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#How_has_eClerx_Services_performed_financially\" title=\"How has eClerx Services performed financially?\">How has eClerx Services performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#What_risks_should_investors_check_before_buying_blood_test_lab_urea_and_data_process_stocks\" title=\"What risks should investors check before buying blood test lab, urea and data process stocks?\">What risks should investors check before buying blood test lab, urea and data process stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks-roadmap-badland-list\/#Is_this_list_of_blood_test_lab_urea_and_data_process_stocks_investment_advice\" title=\"Is this list of blood test lab, urea and data process stocks investment advice?\">Is this list of blood test lab, urea and data process stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Blood_Test_Lab_Urea_and_Data_Process_Stocks\"><\/span><strong>What Are Blood Test Lab, Urea and Data Process Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Blood test lab, urea and data process stocks<\/strong> are listed companies that run pathology labs and collection centres, make urea and other fertilisers for farmers, and provide data and process services to global clients. Their earnings depend on test volumes, farm demand and client outsourcing budgets.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Blood_Test_Lab_Urea_and_Data_Process_Stocks_at_a_Glance\"><\/span><strong>Blood Test Lab, Urea and Data Process Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/metropolis\/metropolis-healthcare-ltd-share-price-today\">Metropolis Healthcare<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">564.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10,780<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">53.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/chamblfert\/chambal-fertilisers-and-chemicals-ltd-share-price-today\">Chambal Fertilisers and Chemicals<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">371.65<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15,339<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.10<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/eclerx\/eclerx-services-ltd-share-price-today\">eClerx Services<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,500.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18,062<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">27.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.15<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Metropolis Healthcare and Chambal Fertilisers and Chemicals trade at a <strong>P\/E<\/strong> below the industry P\/E, while eClerx Services trades above it, which reflects the growth the market already expects. Readers comparing blood test lab, urea and data process stocks should look at <strong>return on equity<\/strong> and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in blood test lab, urea and data process stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Blood_Test_Lab_Urea_and_Data_Process_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Blood Test Lab, Urea and Data Process Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Blood test lab, urea and data process stocks<\/strong> have a strong roadmap in India because wider access to tests, steady farm demand and rising client spending on data and process work keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Pathology.<\/strong> Doctors order more tests.<\/li>\n<li><strong>Fertilisers.<\/strong> Farmers need crop nutrients.<\/li>\n<li><strong>Process outsourcing.<\/strong> Clients hand over data operations.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Metropolis_Healthcare_Features_Among_These_Blood_Test_Lab_Urea_and_Data_Process_Stocks\"><\/span><strong>Why Metropolis Healthcare Features Among These Blood Test Lab, Urea and Data Process Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the blood test lab, urea and data process stocks on this list, Metropolis Healthcare, headquartered in Mumbai, is a pathology and diagnostics company that runs a national network of laboratories, patient service centres and collection points, and also serves hospitals and corporate clients.<\/p>\n<p>Revenue rose from Rs 1,246 crore in FY22 to Rs 1,671 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 143 crore in FY23 to Rs 191 crore in FY26, which works out to a compound annual growth rate of 10.1%.<\/p>\n<p>In the June 2026 quarter, revenue grew 15.7% year on year to Rs 455 crore, while net profit rose 25.7% to Rs 56.9 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.15 and a <strong>market capitalisation<\/strong> of Rs 10,780 crore. The stock trades at a <strong>P\/E<\/strong> of 53.1, below the industry P\/E of 59.6.<\/p>\n<p><strong>Roadmap:<\/strong> The company is deepening its presence in existing regions while extending into new cities through collection points and partner labs. A larger share of specialised tests in oncology, genetics and wellness lifts revenue per patient and helps its mix.<\/p>\n<p><strong>What to watch:<\/strong> Follow test volumes per patient and the pace at which newer regions turn profitable.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Chambal_Fertilisers_and_Chemicals_Features_Among_These_Blood_Test_Lab_Urea_and_Data_Process_Stocks\"><\/span><strong>Why Chambal Fertilisers and Chemicals Features Among These Blood Test Lab, Urea and Data Process Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the diagnostics chain, nitrogen fertiliser and data services shares on this list, Chambal Fertilisers and Chemicals makes urea at its plants in Rajasthan and trades in other fertilisers, crop protection chemicals and agri inputs.<\/p>\n<p>Revenue rose from Rs 16,137 crore in FY22 to Rs 20,921 crore in FY26, a compound annual growth rate of 6.7%. Net profit grew from Rs 1,566 crore in FY22 to Rs 1,953 crore in FY26, which works out to a compound annual growth rate of 5.7%.<\/p>\n<p>The company has a return on equity of 18.8%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 15,339 crore. The stock trades at a P\/E of 8.0, below the industry P\/E of 21.2.<\/p>\n<p><strong>Roadmap:<\/strong> The company has a strong urea franchise with large volumes and a wide dealer network. It is widening into crop protection and specialty agri inputs, which adds higher-margin revenue to the base fertiliser business.<\/p>\n<p><strong>What to watch:<\/strong> Track fertiliser subsidy policy updates and the monsoon, which both influence volumes and working capital.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_eClerx_Services_Features_Among_These_Blood_Test_Lab_Urea_and_Data_Process_Stocks\"><\/span><strong>Why eClerx Services Features Among These Blood Test Lab, Urea and Data Process Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, eClerx Services, based in Mumbai, offers data analytics, digital operations and process services to financial services, retail and technology clients.<\/p>\n<p>The company has a return on equity of 27.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 18,062 crore. The stock trades at a P\/E of 24.8, above the industry P\/E of 17.5.<\/p>\n<p>Revenue rose from Rs 2,185 crore in FY22 to Rs 4,218 crore in FY26, a compound annual growth rate of 17.9%. Net profit grew from Rs 418 crore in FY22 to Rs 706 crore in FY26, which works out to a compound annual growth rate of 14.0%. In the June 2026 quarter, revenue grew 23.8% year on year to Rs 1,170 crore, while net profit rose 16.0% to Rs 164 crore.<\/p>\n<p><strong>Roadmap:<\/strong> Clients are buying more data and automation work, and eClerx is adding artificial intelligence-led offerings. A balance sheet with little debt and high returns on capital gives it flexibility to invest and return cash.<\/p>\n<p><strong>What to watch:<\/strong> Monitor client additions and growth in digital offerings.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Metropolis_Healthcare_vs_Chambal_Fertilisers_and_Chemicals_vs_eClerx_Services_on_Key_Financials\"><\/span><strong>Metropolis Healthcare vs Chambal Fertilisers and Chemicals vs eClerx Services on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three blood test lab, urea and data process stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Metropolis Healthcare<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,246<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,671<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">191<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Chambal Fertilisers and Chemicals<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16,137<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20,921<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,953<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">eClerx Services<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,185<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,218<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">706<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.7%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>eClerx Services posts the highest return on equity in this group at 27.6%. Chambal Fertilisers and Chemicals has the largest FY26 revenue at Rs 20,921 crore, and eClerx Services shows the fastest revenue growth with a 17.9% compound annual rate. A useful habit with <strong>blood test lab, urea and data process stocks<\/strong> is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several pathology labs, fertilisers and digital operations stocks instead of one name, which keeps a single result from deciding the outcome.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Blood_Test_Lab_Urea_and_Data_Process_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Blood Test Lab, Urea and Data Process Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these blood test lab, urea and data process stocks, the main points are: Long-term diagnostics chain, nitrogen fertiliser and data services shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Capacity ramp up.<\/strong> New hospitals take time to fill beds and reach full returns.<\/li>\n<li><strong>Farm cycles.<\/strong> Tractor and crop input demand follows the monsoon and farm incomes.<\/li>\n<li><strong>Client spending.<\/strong> Technology budgets can vary with global conditions.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter blood test lab, urea and data process stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Blood_Test_Lab_Urea_and_Data_Process_Stocks\"><\/span><strong>Final Thoughts on Blood Test Lab, Urea and Data Process Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Blood test lab, urea and data process stocks<\/strong> work best when investors track growth, valuation and return on equity side by side. Metropolis Healthcare, Chambal Fertilisers and Chemicals and eClerx Services each have a clear plan to grow. Based on the 18 November 2026 close, Metropolis Healthcare trades at Rs 564.3, Chambal Fertilisers and Chemicals at Rs 371.65 and eClerx Services at Rs 1,500.1. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these blood test lab, urea and data process stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track blood test lab, urea and data process stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_blood_test_lab_urea_and_data_process_stocks\"><\/span><strong>What are blood test lab, urea and data process stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Blood test lab, urea and data process stocks are listed companies that run pathology labs and collection centres, make urea and other fertilisers for farmers, and provide data and process services to global clients. Their earnings depend on test volumes, farm demand and client outsourcing budgets. This list looks at three of them, Metropolis Healthcare, Chambal Fertilisers and Chemicals and eClerx Services, using reported FY22 to FY26 financials and the 18 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_blood_test_lab_urea_and_data_process_stocks_are_covered_in_this_list\"><\/span><strong>Which blood test lab, urea and data process stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Metropolis Healthcare, Chambal Fertilisers and Chemicals and eClerx Services. Based on the 18 November 2026 close, Metropolis Healthcare traded at Rs 564.3, Chambal Fertilisers and Chemicals at Rs 371.65 and eClerx Services at Rs 1,500.1. Their return on equity ranges from <strong>12.6% to 27.6%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 6.7% to 17.9%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_blood_test_lab_urea_and_data_process_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do blood test lab, urea and data process stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> <strong>Blood test lab, urea and data process stocks<\/strong> have a strong roadmap in India because wider access to tests, steady farm demand and rising client spending on data and process work keep widening the market for these companies. The main drivers are as follows. Pathology. Doctors order more tests. Fertilisers. Farmers need crop nutrients. Process outsourcing. Clients hand over data operations. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Metropolis_Healthcare_performed_financially\"><\/span><strong>How has Metropolis Healthcare performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,246 crore in FY22 to Rs 1,671 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 143 crore in FY23 to Rs 191 crore in FY26, which works out to a compound annual growth rate of 10.1%. In the June 2026 quarter, revenue grew 15.7% year on year to Rs 455 crore, while net profit rose 25.7% to Rs 56.9 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 10,780 crore. The stock trades at a P\/E of 53.1, below the industry P\/E of 59.6. Looking ahead, the company is deepening its presence in existing regions while extending into new cities through collection points and partner labs. A larger share of specialised tests in oncology, genetics and wellness lifts revenue per patient and helps its mix.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Chambal_Fertilisers_and_Chemicals_performed_financially\"><\/span><strong>How has Chambal Fertilisers and Chemicals performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 16,137 crore in FY22 to Rs 20,921 crore in FY26, a compound annual growth rate of 6.7%. Net profit grew from Rs 1,566 crore in FY22 to Rs 1,953 crore in FY26, which works out to a compound annual growth rate of 5.7%. The company has a return on equity of 18.8%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 15,339 crore. The stock trades at a P\/E of 8.0, below the industry P\/E of 21.2. Looking ahead, the company has a strong urea franchise with large volumes and a wide dealer network. It is widening into crop protection and specialty agri inputs, which adds higher-margin revenue to the base fertiliser business.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_eClerx_Services_performed_financially\"><\/span><strong>How has eClerx Services performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 2,185 crore in FY22 to Rs 4,218 crore in FY26, a compound annual growth rate of 17.9%. Net profit grew from Rs 418 crore in FY22 to Rs 706 crore in FY26, which works out to a compound annual growth rate of 14.0%. In the June 2026 quarter, revenue grew 23.8% year on year to Rs 1,170 crore, while net profit rose 16.0% to Rs 164 crore. The company has a return on equity of 27.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 18,062 crore. The stock trades at a P\/E of 24.8, above the industry P\/E of 17.5. Looking ahead, clients are buying more data and automation work, and eClerx is adding artificial intelligence-led offerings. A balance sheet with little debt and high returns on capital gives it flexibility to invest and return cash.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_blood_test_lab_urea_and_data_process_stocks\"><\/span><strong>What risks should investors check before buying blood test lab, urea and data process stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying blood test lab, urea and data process stocks. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Farm cycles. Tractor and crop input demand follows the monsoon and farm incomes. Client spending. Technology budgets can vary with global conditions. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_blood_test_lab_urea_and_data_process_stocks_investment_advice\"><\/span><strong>Is this list of blood test lab, urea and data process stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 18 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are blood test lab, urea and data process stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Blood test lab, urea and data process stocks are listed companies that run pathology labs and collection centres, make urea and other fertilisers for farmers, and provide data and process services to global clients. Their earnings depend on test volumes, farm demand and client outsourcing budgets. This list looks at three of them, Metropolis Healthcare, Chambal Fertilisers and Chemicals and eClerx Services, using reported FY22 to FY26 financials and the 18 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which blood test lab, urea and data process stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Metropolis Healthcare, Chambal Fertilisers and Chemicals and eClerx Services. Based on the 18 November 2026 close, Metropolis Healthcare traded at Rs 564.3, Chambal Fertilisers and Chemicals at Rs 371.65 and eClerx Services at Rs 1,500.1. Their return on equity ranges from 12.6% to 27.6%, and their revenue compound annual growth from FY22 to FY26 ranges from 6.7% to 17.9%.\"}},{\"@type\":\"Question\",\"name\":\"Why do blood test lab, urea and data process stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Blood test lab, urea and data process stocks have a strong roadmap in India because wider access to tests, steady farm demand and rising client spending on data and process work keep widening the market for these companies. The main drivers are as follows. Pathology. Doctors order more tests. Fertilisers. Farmers need crop nutrients. Process outsourcing. Clients hand over data operations. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Metropolis Healthcare performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,246 crore in FY22 to Rs 1,671 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 143 crore in FY23 to Rs 191 crore in FY26, which works out to a compound annual growth rate of 10.1%. In the June 2026 quarter, revenue grew 15.7% year on year to Rs 455 crore, while net profit rose 25.7% to Rs 56.9 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 10,780 crore. The stock trades at a P\/E of 53.1, below the industry P\/E of 59.6. Looking ahead, the company is deepening its presence in existing regions while extending into new cities through collection points and partner labs. A larger share of specialised tests in oncology, genetics and wellness lifts revenue per patient and helps its mix.\"}},{\"@type\":\"Question\",\"name\":\"How has Chambal Fertilisers and Chemicals performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 16,137 crore in FY22 to Rs 20,921 crore in FY26, a compound annual growth rate of 6.7%. Net profit grew from Rs 1,566 crore in FY22 to Rs 1,953 crore in FY26, which works out to a compound annual growth rate of 5.7%. The company has a return on equity of 18.8%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 15,339 crore. The stock trades at a P\/E of 8.0, below the industry P\/E of 21.2. Looking ahead, the company has a strong urea franchise with large volumes and a wide dealer network. It is widening into crop protection and specialty agri inputs, which adds higher-margin revenue to the base fertiliser business.\"}},{\"@type\":\"Question\",\"name\":\"How has eClerx Services performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 2,185 crore in FY22 to Rs 4,218 crore in FY26, a compound annual growth rate of 17.9%. Net profit grew from Rs 418 crore in FY22 to Rs 706 crore in FY26, which works out to a compound annual growth rate of 14.0%. In the June 2026 quarter, revenue grew 23.8% year on year to Rs 1,170 crore, while net profit rose 16.0% to Rs 164 crore. The company has a return on equity of 27.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 18,062 crore. The stock trades at a P\/E of 24.8, above the industry P\/E of 17.5. Looking ahead, clients are buying more data and automation work, and eClerx is adding artificial intelligence-led offerings. A balance sheet with little debt and high returns on capital gives it flexibility to invest and return cash.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying blood test lab, urea and data process stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying blood test lab, urea and data process stocks. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Farm cycles. Tractor and crop input demand follows the monsoon and farm incomes. Client spending. Technology budgets can vary with global conditions. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of blood test lab, urea and data process stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 18 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Blood Test Lab, Urea and Data Process Stocks with a strong future roadmap: Metropolis Healthcare, Chambal Fertilisers and Chemicals and eClerx Services. Compare price, valuation, return on equity and revenue growth as of 17 November 2026.<\/p>\n","protected":false},"author":34,"featured_media":355932,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[3803,21712,14240,5646,14101,26544,7226,26542,26543,26541],"class_list":["post-355933","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-best-stocks","tag-blood-test-lab","tag-chambal-fertilisers-and-chemicals","tag-diagnostics-chain","tag-eclerx-services","tag-fertilisers-and-digital-operations-stocks","tag-metropolis-healthcare","tag-nitrogen-fertiliser-and-data-services-shares","tag-pathology-labs","tag-urea-and-data-process-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["355932"],"rank_math_title":["Blood Test Lab, Urea and Process Outsourcing Stocks"],"rank_math_description":["Compare 3 blood test lab, urea and data process stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 17 Nov 2026."],"rank_math_focus_keyword":["blood test lab, urea and data process stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-pathology-labs-chain-fertilisers-maker-and-digital-operations-company-stocks.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/355933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=355933"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/355933\/revisions"}],"predecessor-version":[{"id":355934,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/355933\/revisions\/355934"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/355932"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=355933"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=355933"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=355933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}